EU MDR & IVDR Regulatory Strategy Services

EU MDR and IVDR regulatory strategy services for medical devices and IVDs. Gap analysis, roadmap, and NB-ready submissions.

What We Do

EU MDR & IVDR Regulatory Strategy Services

Bioexcel supports manufacturers with end-to-end EU MDR and IVDR regulatory strategy, ensuring structured planning, evidence alignment, and Notified Body–ready submissions across the product lifecycle.

SEND YOUR ENQUIRY

Engage Our EU MDR Strategy Team

Integrated Multi-Region Regulatory Strategy

Bioexcel develops regulatory roadmaps aligned with global compliance requirements, ensuring structured evidence planning, technical documentation readiness, and authority-facing submission strategy across the product lifecycle.

We operate at the intersection of regulatory intelligence, clinical evidence integration, and risk-based compliance architecture.

Plan Your Global Regulatory Roadmap

DIFFERENTIATION BLOCK (Add This — Important)

Beyond Documentation. Strategic Regulatory Positioning.

We don’t only prepare files.

We design regulatory positioning strategies that anticipate:

Notified Body review behavior

FDA deficiency trends

CDSCO query patterns

Post-market surveillance expectations

Lifecycle evidence requirements

Our strategy reduces regulatory uncertainty and strengthens approval confidence.

Discuss Your Global Regulatory Strategy

CAPABILITIES & REGULATORY (Rewrite This Entire Section)

Regulatory Strategy & Execution Capabilities

Strategic Planning

Device classification & conformity route determination (EU / US / India / UK / AU / CA)

Multi-country regulatory pathway mapping

Regulatory gap assessment & remediation planning

Technical documentation architecture (STED / EU Technical File / US submissions)

Clinical & performance evidence integration (CER / PER / PMCF / PMS / RWE)

Global submission sequencing strategy

What We Support

Bioexcel supports manufacturers with end-to-end regulatory strategy across:

EU MDR (2017/745) & IVDR (2017/746)
US FDA (510(k), De Novo,
PMA, IDE)
CDSCO (India Medical Device
Rules 2017)
UK MHRA (UKCA)
TGA (Australia)
Health Canada
Other international regulatory jurisdictions

From classification to submission planning, we build structured, regulator-ready pathways that accelerate approvals and reduce review cycles.

Capabilities & Regulatory

Capabilities – Device classification & conformity assessment route – MDR/IVDR gap assessment & remediation roadmap – Evidence strategy (CER/PER/PMCF integration) – NB engagement & submission planning

Regulatory – Alignment EU MDR (2017/745), EU IVDR (2017/746), MDCG guidance

Discuss Your EU MDR / IVDR Strategy

EU MDR & IVDR Regulatory Strategy Services_page-0004

Regulatory Alignment

We align regulatory strategy with:

EU MDR (2017/745)
EU IVDR (2017/746)
MDCG guidance documents
US FDA (21 CFR Parts 807, 812, 814, 820)
CDSCO MDR 2017 & CDSCO guidance
ISO 13485 & ISO 14155
ICH-GCP (where applicable)

Our approach ensures regulator-facing defensibility and structured submission readiness.

UKCA & MHRA Regulatory Support_page-0001

Frequently Asked Questions (FAQ)

Does Bioexcel guarantee regulatory approval?Bioexcelife2026-02-10T09:22:59+00:00

Does Bioexcel guarantee regulatory approval?

No. Bioexcel supports compliant preparation and strategy; final approval decisions rest with regulatory
authorities.

Can the same clinical evidence be used across regions?Bioexcelife2026-02-10T09:24:10+00:00

Can the same clinical evidence be used across regions?

Often yes, with region-specific adaptations based on regulatory requirements.